JP2023527454A5 - - Google Patents

Info

Publication number
JP2023527454A5
JP2023527454A5 JP2022573444A JP2022573444A JP2023527454A5 JP 2023527454 A5 JP2023527454 A5 JP 2023527454A5 JP 2022573444 A JP2022573444 A JP 2022573444A JP 2022573444 A JP2022573444 A JP 2022573444A JP 2023527454 A5 JP2023527454 A5 JP 2023527454A5
Authority
JP
Japan
Prior art keywords
composition according
administered
infantile spasms
day
mct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022573444A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527454A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/034883 external-priority patent/WO2021243226A1/en
Publication of JP2023527454A publication Critical patent/JP2023527454A/ja
Publication of JP2023527454A5 publication Critical patent/JP2023527454A5/ja
Pending legal-status Critical Current

Links

JP2022573444A 2020-05-29 2021-05-28 中鎖トリグリセリドを使用して点頭てんかんを処置する方法 Pending JP2023527454A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063032111P 2020-05-29 2020-05-29
US63/032,111 2020-05-29
US202163176747P 2021-04-19 2021-04-19
US63/176,747 2021-04-19
PCT/US2021/034883 WO2021243226A1 (en) 2020-05-29 2021-05-28 Methods for the treatment of infantile spasms using medium chain triglycerides

Publications (2)

Publication Number Publication Date
JP2023527454A JP2023527454A (ja) 2023-06-28
JP2023527454A5 true JP2023527454A5 (https=) 2024-05-28

Family

ID=78744111

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022573444A Pending JP2023527454A (ja) 2020-05-29 2021-05-28 中鎖トリグリセリドを使用して点頭てんかんを処置する方法

Country Status (8)

Country Link
US (1) US20230181512A1 (https=)
EP (1) EP4157250A4 (https=)
JP (1) JP2023527454A (https=)
KR (1) KR20230018462A (https=)
CN (1) CN115884766A (https=)
AU (1) AU2021281426A1 (https=)
CA (1) CA3184353A1 (https=)
WO (1) WO2021243226A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3595638A4 (en) * 2017-03-15 2020-09-16 Cerecin Inc. PHARMACEUTICAL COMPOSITIONS WITH HIGH DRUG LOADS BASED ON MEDIUM-CHAIN TRIGLYCERIDES AND RELATED METHODS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL164089A0 (en) * 2002-04-30 2005-12-18 Suntory Ltd Astaxanthin medium-chain fatty acidester, production method of the same, and composition comprising the same
KR20070034591A (ko) * 2004-06-17 2007-03-28 위스콘신 얼럼나이 리서어치 화운데이션 발작 및 발작병을 치료하기 위한 화합물 및 방법
CA2882708A1 (en) * 2012-08-21 2014-02-27 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
US11331279B2 (en) * 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
CA2986268C (en) * 2015-05-28 2024-01-02 Insys Development Company, Inc. Stable cannabinoid formulations
EP3462885A4 (en) * 2016-05-27 2020-01-22 Insys Development Company, Inc. STABLE CANNABINOID FORMULATIONS
EP3481387A4 (en) * 2016-08-11 2020-04-08 Ovid Therapeutics Inc METHOD AND COMPOSITIONS FOR TREATING EPILEPTIC DISEASES
AU2017347778A1 (en) * 2016-10-24 2019-05-16 University Of South Florida Delaying latency to seizure by combinations of ketone supplements
CN110678173B (zh) * 2017-04-10 2023-03-28 维塔弗洛国际有限公司 用于治疗癫痫的组合物
US10682317B2 (en) * 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation

Similar Documents

Publication Publication Date Title
CN1268328C (zh) 辅酶q与二十碳五烯酸(epa)
JP5441287B2 (ja) 心血管事象を予防するための必須脂肪酸
CA2549103C (en) Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
JPH02104522A (ja) 脂肪酸を含有する医薬用組成物
KR920000324A (ko) 필수 지방산 처리법
US20140271844A1 (en) Compositions containing nitro fatty acids
US20160081962A1 (en) Nutritional or dietary supplements containing fatty acids and nitrite
US11109607B2 (en) Oil-based compositions for enhancing oral health and general wellness in humans
KR20240032789A (ko) 시클로-히스프로를 유효성분으로 포함하는 비만 예방 또는 치료용 약제학적 조성물
JPWO2009038095A1 (ja) セサミン類とビタミンb1類とを配合した組成物
JP2023527454A5 (https=)
EP4135532A1 (en) A nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation
JPH09509139A (ja) 酪酸エステル細胞分化薬
JP2023521665A5 (https=)
CN100355421C (zh) 二十二碳六烯酸作为活性物质制备用于治疗脂肪代谢障碍的药物的用途
CN116490181A (zh) 在人中施用β-羟基丁酸和相关化合物用于治疗和/或预防呼吸道疾病
EP0739629B1 (fr) Nouvelles associations comprenant du (-)hydroxycitrate et présentant notamment de nouvelles activités thérapeutiques
JP2019510745A5 (https=)
JP2003169633A (ja) 血圧降下、心臓強化、動脈硬化防止、血管保護、抗疲労、運動機能向上、エネルギー代謝効率向上、抗酸化などの諸効果を有する栄養補助食品。
JP2024526939A5 (https=)
JP2021147394A (ja) 牛樟芝の酒酔い解消及び/又はアルコール代謝増加に用いる用途
JP2023531919A5 (https=)
JP2020503388A (ja) 悪液質を予防及び/又は処置するためのオメガ−3脂肪酸組成物
JP7422160B2 (ja) アクアポリン3の発現調節を介した腸機能改善用組成物及びその使用
US11896611B1 (en) Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation